Cargando…
Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer
To elucidate the role of a type II transmembrane serine protease, ST14/Prss14, during breast cancer progression, we utilized publically accessible databases including TCGA, GEO, NCI-60, and CCLE. Survival of breast cancer patients with high ST14/Prss14 expression is significantly poor in estrogen re...
Autores principales: | Kim, Sauryang, Yang, Jae Woong, Kim, Chungho, Kim, Moon Gyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085182/ https://www.ncbi.nlm.nih.gov/pubmed/27167193 http://dx.doi.org/10.18632/oncotarget.9155 |
Ejemplares similares
-
Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies
por: Kim, Ki Yeon, et al.
Publicado: (2019) -
Intramembrane proteolysis of an extracellular serine protease, epithin/PRSS14, enables its intracellular nuclear function
por: Cho, Youngkyung, et al.
Publicado: (2020) -
Environment-Sensitive Ectodomain Shedding of Epithin/PRSS14 Increases Metastatic Potential of Breast Cancer Cells by Producing CCL2
por: Jang, Jiyoung, et al.
Publicado: (2022) -
A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase CβII
por: Yoon, Joobyoung, et al.
Publicado: (2020) -
Critical Adjuvant Influences on Preventive Anti-Metastasis Vaccine Using a Structural Epitope Derived from Membrane Type Protease PRSS14
por: Kim, Ki Yeon, et al.
Publicado: (2020)